Constellis was established in 2010 by a group of operators and investors who sought to combine best-in-class brands, assets and people within the complex risk management industry. Today, the leading provider of risk management and operational support services worldwide, Constellis combines the legacy capabilities and experience of ACADEMI, Triple Canopy, Olive Group, Centerra, Edinburgh International ...
from EMS via xlomafota13 on Inoreader http://ift.tt/2wjvozm
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Ravulizumab (ravulizumab-cwvz; ULTOMIRIS™), a humanized monoclonal antibody, is a complement C5 inhibitor developed by Alexion Ph...
-
http://bit.ly/2TO0eLw
-
Abstract Purpose To analyze the differences in outcomes between primary and secondary definitive osteosynthesis for fractures of the lower...
-
Abstract Objective Long-acting synthetic somatostatin analogues (SSA) are an essential part of the treatment of neuroendocrine neoplasms...
-
http://sfaki.blogspot.com/2017/06/monoclonal-antibodies-against-il-5-or.html Alexandros Sfakianakis Anapafseos 5 . Agios Nikolaos Crete.Gree...
-
Abstract Background Depression following the diagnosis of breast cancer has been well documented, and occurs in as many as 40% of women....
-
CHARLOTTE HALL, Md. — EMS job seekers are given specific reasons to not apply for a position in a job posting for paramedics, EMTs and dispa...
-
Academic Radiology from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2t1H331
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου